/
Metabolic & Endocrine
Diabetes Mellitus
357
Pipeline Programs↗
844
Active Trials↗
277
Companies Involved↗
Diabetes Mellitus is a highly competitive landscape with 357 programs across 277 companies. The most active players are Haisco Pharmaceutical Group Co., Ltd., Eli Lilly, Sunshine Lake Pharma Co., Ltd.. 78 programs are in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical197
Phase 132
Phase 250
Phase 378
Approved
No programs
Analysis
Modality Breakdown
94%
Small molecule
297 of 315 classified programs — the dominant modality here.
Small molecule leads; the ring shows all 315 classified programs, each share of the total. Modality classified for 95% of 357 pipeline programs.
Analysis
Trial Status
4,640
clinical trials
Completed3,098 · 67%
Recruiting411 · 9%
Unknown status317 · 7%
Terminated249 · 5%
Not yet recruiting219 · 5%
Active, not recruiting182 · 4%
Other164 · 4%
Clinical Trials
Trial Activity
4640 trials
The Cognitive Protective Effect of VR-based Cognitive Training in Type 2 Diabetes Patients With Mild Cognitive Impairment：A Prospective, Randomized, Open-Label, Parallel-Group Pilot Study
Recruiting·TThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School·Preclinical·NCT07650318·40 enrolled
Involvement of Muscle Mitochondrial Dysfunction in Frailty in Older Adults. Role of Exercise
Recruiting·FFundación para la Investigación del Hospital Clínico de Valencia·Preclinical·NCT07828847·120 enrolled
Type 1 Diabetes Extension Study
Recruiting·National Institute of Allergy and Infectious Diseases (NIAID)·N/A·NCT02734277·111 enrolled
Early Tracking of Childhood Health Determinants Study
Recruiting·National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)·N/A·NCT03481829·1,500 enrolled
Page 1 of 310
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)